Huang, C.-W.; Yang, C.-T.; Su, P.-Y.; Chen, Y.-Y.; Huang, S.-P.; Yen, H.-H.
Chronic Hepatitis B Relapse Rates after Cessation of Tenofovir Alafenamide and Entecavir Therapy. Biomedicines 2023, 11, 752.
https://doi.org/10.3390/biomedicines11030752
AMA Style
Huang C-W, Yang C-T, Su P-Y, Chen Y-Y, Huang S-P, Yen H-H.
Chronic Hepatitis B Relapse Rates after Cessation of Tenofovir Alafenamide and Entecavir Therapy. Biomedicines. 2023; 11(3):752.
https://doi.org/10.3390/biomedicines11030752
Chicago/Turabian Style
Huang, Chih-Wen, Chen-Ta Yang, Pei-Yuan Su, Yang-Yuan Chen, Siou-Ping Huang, and Hsu-Heng Yen.
2023. "Chronic Hepatitis B Relapse Rates after Cessation of Tenofovir Alafenamide and Entecavir Therapy" Biomedicines 11, no. 3: 752.
https://doi.org/10.3390/biomedicines11030752
APA Style
Huang, C.-W., Yang, C.-T., Su, P.-Y., Chen, Y.-Y., Huang, S.-P., & Yen, H.-H.
(2023). Chronic Hepatitis B Relapse Rates after Cessation of Tenofovir Alafenamide and Entecavir Therapy. Biomedicines, 11(3), 752.
https://doi.org/10.3390/biomedicines11030752